TickerFacts.

Korsana Biosciences, Inc. (KRSA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$40.61M
Year ended 2022-12-31
2018-12-31: -$100.94M2019-12-31: -$109.10M2020-12-31: -$74.01M2021-12-31: -$36.52M2022-12-31: -$40.61M-$40.61M
2018-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$40.61Mn/m2024-03-05, From 2022-01-01
2021-12-31-$36.52Mn/m2023-03-22, From 2021-01-01
2020-12-31-$74.01Mn/m2022-02-24, From 2020-01-01
2019-12-31-$109.10Mn/m2021-02-25, From 2019-01-01
2018-12-31-$100.94Mn/a2020-03-12, From 2018-01-01